Novel S2 subunit-specific antibody with broad neutralizing activity against SARS-CoV-2 variants of concern

IntroductionSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), had a major impact on both the global health and economy. Numerous virus-neutralizing antibodies were developed against the S1 subunit of SARS-CoV-2 spike (S) protein...

Full description

Bibliographic Details
Main Authors: Chang-Kyu Heo, Won-Hee Lim, Jihyun Yang, Sumin Son, Sang Jick Kim, Doo-Jin Kim, Haryoung Poo, Eun-Wie Cho
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-12-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1307693/full